Literature DB >> 29800609

Analysis of snake venom composition and antimicrobial activity.

Robert A Charvat1, Raeshelle M Strobel2, Megan A Pasternak2, Sarah M Klass2, Justin L Rheubert2.   

Abstract

With the threat of a post-antibiotic era looming, the search for new and effective antibiotics from novel sources is imperative. Not only has crude snake venom been shown to be effective, but specific components within the venoms, such as Phospholipase A2s and l-amino acid oxidases have been isolated and demonstrated to be effective as well. Despite numerous studies being completed on snake venoms, there is a heavy bias towards utilizing the venoms from the highly toxic Elapidae and Viperidae species. Very few studies have been conducted on the less toxic, but taxonomically more diverse, Colubridae. Furthermore, an extensive review of the literature examining the efficacy and potential specificity of these venoms has not been completed. Therefore, the aims of this study were to elucidate any similarities in snake venoms as well as investigate the efficacy of snake venom antimicrobial properties towards morphologically and metabolically diverse microbial classes and the prevalence of snake species with antimicrobial properties within each snake family. The results indicate that snake venoms and their isolated components are powerful antimicrobial agents but vary in efficacy towards different microbial classes. Furthermore, due to similarities in venom composition, and limited preliminary studies, the less toxic Colubridae family may be a fruitful area of research to find novel antimicrobial agents that are less harmful to humans.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Bacteria; Parasite; Snake; Venom

Mesh:

Substances:

Year:  2018        PMID: 29800609     DOI: 10.1016/j.toxicon.2018.05.016

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  4 in total

1.  Isolation and characterization of cytotoxic and insulin-releasing components from the venom of the black-necked spitting cobra Naja nigricollis (Elapidae).

Authors:  J M Conlon; Samir Attoub; Vishal Musale; Jérôme Leprince; Nicholas R Casewell; Libia Sanz; Juan J Calvete
Journal:  Toxicon X       Date:  2020-03-18

Review 2.  Snake Venoms in Drug Discovery: Valuable Therapeutic Tools for Life Saving.

Authors:  Tarek Mohamed Abd El-Aziz; Antonio Garcia Soares; James D Stockand
Journal:  Toxins (Basel)       Date:  2019-09-25       Impact factor: 4.546

3.  Evaluation of Antifungal Activity of Naja pallida and Naja mossambica Venoms against Three Candida Species.

Authors:  Ewelina Kuna; Aleksandra Bocian; Konrad K Hus; Vladimir Petrilla; Monika Petrillova; Jaroslav Legath; Anna Lewinska; Maciej Wnuk
Journal:  Toxins (Basel)       Date:  2020-08-04       Impact factor: 4.546

4.  Predicting antibacterial activity from snake venom proteomes.

Authors:  Justin L Rheubert; Michael F Meyer; Raeshelle M Strobel; Megan A Pasternak; Robert A Charvat
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.